🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06011694
Recruiting Observational

The Jinling Cohort

NCT06011694 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing Shihejiyin Technology, Inc.
Phase
Observational
Started
2022-06-15
Last updated
2023-08-25

Condition(s) studied

CancerMulti Cancer Early ScreeningLiquid Biopsy

Investigational drug(s) / intervention(s)

MERCURY test, health questionnaires and annual routine physical exams

MERCURY test, health questionnaires and annual routine physical exams: Each participant will undergo peripheral blood collection for MERCURY test, health questionnaires and annual routine physical exams once a year for three consecutive years, then followed up two additional years.

Study summary

The Jinling Cohort is a prospective, multicenter cohort study in which 15,000 eligible individuals aged 45-75 in Nanjing China will be enrolled.

Eligibility

Sex
ALL
Min age
45 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: 1、45-75 years of age; 2、Willing and able to undergo blood sample collection, health questionnaires and annual routine physical exams once a year for three consecutive years; 3、Residents in Nanjing; 4、Fully understand the study and able to provide a written informed consent Exclusion Criteria: 1. Pregnant women; 2. Individuals who have history of cancer or current diagnosis of cancer; 3. Individuals who have organ transplant or prior non-autologous (allogeneic) bone marrow or stem cell transplant; 4. Individulas who have blood transfusion within 30 days prior to the blood draw; 5. Individuals who have an acute infection or inflammation within 14 days prior to the blood draw; 6. Individuals who have taken medication with anti-tumor effects within 30 days prior to the blood draw; 7. Individuals who will not be able to comply with the protocol procedures judged by researchers

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Nanjing Jiangbei People's Hospital Nanjing Jiangsu Recruiting
The Fourth Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06011694 on ClinicalTrials.gov ↗ ← All trials in China